RxDoctor Payments Data

Terry Perrine, MD

Family Medicine · Tupelo, MSNPI 1033157391

Payments from drug & device makers

$1,652in general payments, 2019–2025

Across 59 payments — averaging $28.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$303
  • Otsuka America Pharmaceutical, Inc.$237
  • AstraZeneca$219
  • Pfizer$163
  • Boehringer Ingelheim$114
  • Johnson & Johnson$85
  • plus $532 from 11 others

What the payments were for

  • Food & beverage$1,652100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,652 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$166,967
Medicare patients
521
Services billed
2,139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban378$71,607
XareltoRivaroxaban58$16,960
JardianceEmpagliflozin43$11,956
LinzessLinaclotide15$8,378
FarxigaDapagliflozin Propanediol31$5,839
Atorvastatin Calcium823$5,742
BelsomraSuvorexant12$5,328
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen163$4,626
Pantoprazole Sodium481$3,812
LumiganBimatoprost11$3,036
Levothyroxine Sodium485$2,690
OxycontinOxycodone Hcl12$2,575
Gabapentin327$2,351
Omeprazole361$2,266
Donepezil Hcl352$2,176

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$163$71,607378 claims
Johnson & JohnsonXarelto$85$16,96058 claims
Boehringer IngelheimJardiance$114$11,95643 claims
AbbVieLinzess, Lumigan$71$11,41426 claims
AstraZenecaFarxiga$219$5,83931 claims
Novo NordiskNovolog$52$1,24713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Tupelo

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →